Schonfeld Strategic Advisors’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.86M | Sell |
2,272,866
-78,716
| -3% | -$99.2K | 0.02% | 728 |
|
|
2025
Q1 | $2.15M | Buy |
2,351,582
+238,310
| +11% | +$218K | 0.01% | 828 |
|
|
2024
Q4 | $3.36M | Buy |
2,113,272
+467,738
| +28% | +$744K | 0.02% | 584 |
|
|
2024
Q3 | $3.23M | Buy |
1,645,534
+753,678
| +85% | +$1.48M | 0.02% | 587 |
|
|
2024
Q2 | $1.46M | Sell |
891,856
-951,058
| -52% | -$1.56M | 0.01% | 926 |
|
|
2024
Q1 | $9.47M | Buy |
+1,842,914
| New | +$9.47M | 0.06% | 351 |
|
|
2022
Q4 | – | Sell |
-15,344
| Closed | -$162K | – | 2567 |
|
|
2022
Q3 | $162K | Buy |
15,344
+3,644
| +31% | +$38.5K | ﹤0.01% | 2362 |
|
|
2022
Q2 | $64K | Sell |
11,700
-3,100
| -21% | -$17K | ﹤0.01% | 2115 |
|
|
2022
Q1 | $136K | Buy |
+14,800
| New | +$136K | ﹤0.01% | 2072 |
|
|
2021
Q4 | – | Sell |
-10,500
| Closed | -$251K | – | 2032 |
|
|
2021
Q3 | $251K | Buy |
+10,500
| New | +$251K | ﹤0.01% | 1547 |
|